Clinical Outcomes in Patients with Multi-Hit TP53 Chronic Lymphocytic Leukemia Treated with Ibrutinib

Results of a study examining the effect of multi-hit and single hit TP53 mutations on prognosis in patients with CLL. (Abstract only)